A pilot prospective , double-blind , randomized study was conducted to evaluate the ordinary dose of pitavastatin ( @mg daily ) or atorvastatin ( @mg daily ) treatment for @weeks on circulating EPCs in patients with cardiovascular risk such as hypercholesterolemia and type @ diabetes mellitus ( T@DM ) .